A Clinical Study to Evaluate Safety and Performance of PEEK-OPTIMA™ HA Enhanced Interbody Cages in the Lumbar Spine

NACompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

June 27, 2019

Primary Completion Date

May 22, 2023

Study Completion Date

September 25, 2023

Conditions
Degenerative Disc Disease LumbarSpondylolisthesis, Grade 1
Interventions
DEVICE

Device: EVOS Lumbar Interbody System (EVOS-HA)

All subjects will receive the EVOS Lumbar Interbody System (EVOS-HA) device if according to the investigators opinion they are clinically indicated to have surgery treatment for degenerative disc disease and spondylolisthesis.

Trial Locations (2)

19107

Thomas Jefferson University Hospital, Philadelphia

28207

OrthoCarolina Research Institute, Charlotte

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Medical Metrics Diagnostics, Inc

INDUSTRY

lead

Invibio Ltd

INDUSTRY